Review
Current knowledge of obesity's effects in the pre- and periconceptional periods and avenues for future research

https://doi.org/10.1016/j.ajog.2010.06.043Get rights and content

The prevalence of obesity is growing among reproductive-age women. This is concerning because obesity has significant health-related consequences. Aside from the long-term risks of diabetes, heart disease, and some types of cancer, obesity poses immediate threats for young women including subfertility and adverse early and late pregnancy outcomes. Epidemiologic and experimental studies demonstrate associations between prepregnancy obesity and poor reproductive outcomes; however, the mechanisms involved are poorly understood. We discuss current knowledge of the pathophysiology of obesity in early reproductive events and how these events may affect reproductive outcomes including fertility and miscarriage risk. We also discuss avenues for future research and interventions to improve reproductive outcomes for obese women.

Section snippets

Obesity and ovulation

Increased incidence of subfertility among obese women may be attributed in part to the frequent cooccurrence of obesity with polycystic ovary syndrome (PCOS),20 a relatively common condition characterized by hyperandrogenism and anovulation and associated with insulin resistance.21, 22 PCOS is not uncommon in women of normal weight; however, in obese women insulin resistance may lead to clinical features consistent with PCOS.23, 24

Insulin resistance and hyperinsulinemia consequent of obesity

Obesity and the oocyte

Insight into the importance of maternal physiology on oocyte quality can be demonstrated in experimental animal models of maternal diabetes in which there is an increase in granulosa cell apoptosis of the ovarian follicle and impaired oocyte maturation.15, 16, 38 Similar to diabetes, obesity is a condition marked by aberrations in circulating levels of substrates for energy production, and it too appears to have effects on oocyte quality. Visually, these effects appear to be primarily on oocyte

Obesity and the embryo

Embryo quality is affected by poor oocyte quality, and this may be an issue for obese women. This has been documented clinically in obese women undergoing IVF in which embryos derived from oocytes fertilized in vitro are of poorer quality than those derived from normal-weight women.48, 57 On the other hand, IVF studies investigating embryo quality in obese women are conflicting, and their findings on embryo quality may not reflect what truly happens in spontaneous conceptions.58

Another issue to

Obesity and early pregnancy

In addition to increased risks of congenital anomalies, preeclampsia, gestational diabetes, and stillbirth among obese pregnant women,8, 9, 66, 67, 68 there are also data to suggest risk of miscarriage is increased among obese women.69 This association is difficult to study, however, because many spontaneously pregnant women are not followed up closely in early pregnancy and may not ever present for care if they experience a miscarriage. Women undergoing infertility treatment may offer more

Limitations of current evidence and future avenues for research

The bulk of the current data available investigating relationships between obesity and oocytes and early reproduction in spontaneous conception is restricted to work in animal models and a small amount of clinical data from obese women undergoing IVF (Table 2). Unfortunately, the available clinical data are limited in that most women undergoing IVF are treated with gonadotropins. Drug regimens and protocols and response to drugs may vary from patient to patient, with many obese women requiring

References (78)

  • R.L. Robker

    Evidence that obesity alters the quality of oocytes and embryos

    Pathophysiology

    (2008)
  • D.T. Carrell et al.

    Body mass index is inversely related to intrafollicular HCG concentrations, embryo quality and IVF outcome

    Reprod Biomed Online

    (2001)
  • I.S.R. Obeso et al.

    The impact of body mass index (BMI) on ovarian stimulation in young oocyte donors

    Fertil Steril

    (2009)
  • E.S. Jungheim et al.

    Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome

    Fertil Steril

    (2009)
  • M. Metwally et al.

    Effect of increased body mass index on oocyte and embryo quality in IVF patients

    Reprod Biomed Online

    (2007)
  • J. Bellver et al.

    Female obesity impairs in vitro fertilization outcome without affecting embryo quality

    Fertil Steril

    (2010)
  • A.O. Hammoud et al.

    Impact of male obesity on infertility: a critical review of the current literature

    Fertil Steril

    (2008)
  • J.L. Weiss et al.

    Obesity, obstetric complications and cesarean delivery rate—a population-based screening study

    Am J Obstet Gynecol

    (2004)
  • A. Vahratian

    Prevalence of overweight and obesity among women of childbearing age: results from the 2002 National Survey of Family Growth

    Matern Child Health J

    (2009)
  • K.M. Flegal et al.

    Cause-specific excess deaths associated with underweight, overweight, and obesity

    JAMA

    (2007)
  • D.C. Gesink Law et al.

    Obesity and time to pregnancy

    Hum Reprod

    (2007)
  • C.H. Ramlau-Hansen et al.

    Subfecundity in overweight and obese couples

    Hum Reprod

    (2007)
  • L.A. Wise et al.

    An internet-based prospective study of body size and time to pregnancy

    Hum Reprod

    (2010)
  • T.E. O'Brien et al.

    Maternal body mass index and the risk of preeclampsia: a systematic overview

    Epidemiology

    (2003)
  • A. Dokras et al.

    Obstetric outcomes after in vitro fertilization in obese and morbidly obese women

    Obstet Gynecol

    (2006)
  • K.J. Stothard et al.

    Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis

    JAMA

    (2009)
  • G.Q. Chang et al.

    Maternal high-fat diet and fetal programming: increased proliferation of hypothalamic peptide-producing neurons that increase risk for overeating and obesity

    J Neurosci

    (2008)
  • E.A. Nohr et al.

    Severe obesity in young women and reproductive health: the Danish National Birth Cohort

    PLoS One

    (2009)
  • P.M. Catalano et al.

    Fetuses of obese mothers develop insulin resistance in utero

    Diabetes Care

    (2009)
  • M.E. Symonds et al.

    Nutritional programming of the metabolic syndrome

    Nat Rev Endocrinol

    (2009)
  • A.S. Chang et al.

    Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis

    Endocrinology

    (2005)
  • E.S. Jungheim et al.

    The impact of type 1 and type 2 diabetes mellitus on the oocyte and the preimplantation embryo

    Semin Reprod Med

    (2008)
  • A. Wyman et al.

    One-cell zygote transfer from diabetic to nondiabetic mouse results in congenital malformations and growth retardation in offspring

    Endocrinology

    (2008)
  • R. Artal et al.

    Weight gain recommendations in pregnancy and the obesity epidemic

    Obstet Gynecol

    (2010)
  • F. Alvarez-Blasco et al.

    Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women

    Arch Intern Med

    (2006)
  • Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

    Fertil Steril

    (2004)
  • J.E. Nestler

    Obesity, insulin, sex steroids and ovulation

    Int J Obes Relat Metab Disord

    (2000)
  • N. Santoro et al.

    Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: the Study of Women's Health across the Nation (SWAN) daily hormone study

    J Clin Endocrinol Metab

    (2004)
  • Rachon D, Teede H. Ovarian function and obesity—interrelationship, impact on women's reproductive lifespan and...
  • Cited by (145)

    • Obesity and Miscarriage

      2024, Seminars in Reproductive Medicine
    View all citing articles on Scopus

    E.S.J. receives support through the Women's Reproductive Health Research Career Development Program of the National Institutes of Health (K12HD063086-01).

    Reprints not available from the authors.

    View full text